Investor confidence in Turkey is shaken by the shock dismissal of the head of the central bank and the appointment of a new central banker with unorthodox ideas on how to tackle the country’s economic challenges, the increased production of the Covid-19 vaccine is creating shortages of other medicines, and Goldman Sachs bows to workplace complaints by junior bankers. Turkey’s lira tumbles after Erdogan sacks central bank chiefhttps://www.ft.com/content/6be3efd1-a8e9-47a8-abac-966db2d3cf93Push to make Covid vaccines causes US drug shortageshttps://www.ft.com/content/b3ac261e-2675-4679-9356-53aa6d812ad7David Solomon commits to Saturdays off for Goldman Sachs bankershttps://www.ft.com/content/58ca979f-3110-4613-8f85-81d8704cd4ad Hosted on Acast. See acast.com/privacy for more information.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.